FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

American Health Packaging QUETIAPINE Fumarate Tablets 25mg 100 Tablets Recall

QUETIAPINE Fumarate Tablets 25mg 100 Tablets (10x10) Blister card, Rx, Packaged and Di…

American Health Packaging · Columbus, OH

Risk level
Class II
Reported by FDA
Jul 24, 2013
Recall ID
D-802-2013
Check your lot numberHow we source this data

Summary

American Health Packaging recalled QUETIAPINE Fumarate Tablets 25mg 100 Tablets starting Oct 10, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-802-2013 on Jul 24, 2013. Reason: Failed Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg. Status: Terminated.

Why it was recalled

Failed Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.

Product description

QUETIAPINE Fumarate Tablets 25mg 100 Tablets (10x10) Blister card, Rx, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 68084-530-01

Lot numbers, UPCs & expiration codes

Lot 122600 Exp. 03/14

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-802-2013
Classification
Class II
Status
Terminated
Recall initiated
Oct 10, 2012
FDA report date
Jul 24, 2013
Quantity
19060 blister cards
Recall type
Voluntary: Firm initiated
Recalling firm
American Health Packaging

Original FDA data

Every field from FDA enforcement report D-802-2013, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Terminated
Country
United States
Event ID
65683
Address
2550 John Glenn Ave
Address (line 2)
Suite A
Code information
Lot 122600 Exp. 03/14
Postal code
43217-1188
Report date
Jul 24, 2013
Product type
Drugs
Recall number
D-802-2013
Classification
Class II
Recalling firm
American Health Packaging
Product quantity
19060 blister cards
Termination date
Aug 21, 2013
Reason for recall
Failed Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.
Voluntary / mandated
Voluntary: Firm initiated
Product description
QUETIAPINE Fumarate Tablets 25mg 100 Tablets (10x10) Blister card, Rx, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 68084-530-01
Distribution pattern
Nationwide
Recall initiation date
Oct 10, 2012
Initial firm notification
Letter
Center classification date
Jul 15, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-802-2013, published Jul 24, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls